1. Medtech Insight

Abbott First To Offer OTC Continuous Glucose Monitor On Amazon

 
• By Marion Webb

Abbott is now offering its consumer CGM Lingo at Amazon for $49 for a single sensor. Its rival Dexcom also expects to introduce its consumer CGM Stelo on Amazon in Q1.

Lingo
Lingo prototype sensor with screen of smartphone app Abbott shared with its January 2022 announcement of the product's development. • Source: Abbott

Abbott recently announced a deal with retail giant Amazon to offer its over-the-counter glucose monitor (CGM) for people without diabetes wanting to track their glucose levels to improve their metabolic health.

Key Takeaways
  • Abbott now offers its consumer CGM device Lingo on Amazon for $49 for the single sensor, which can work up to 14 days.

The company announced the deal on 25 February. Lingo, which is based on Abbott’s existing FreeStyle Libre diabetes monitoring platform,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Medtech Insight

More from Digital Technologies

Medtronic Announces Collaboration To Create A ‘New Era’ in Surgical Training

 
• By Brian Bossetta

Medtronic is teaming up with IRCAD North America to build high-tech training and education experiences for surgeons and medical professionals in cardiovascular, neuroscience, and minimally invasive surgical specialties. The move could also further position Medtronic to seize on the growing robotics

GE HealthCare Launches Intraoperative Ultrasound Product Series: bkActiv S

 
• By Natasha Barrow

GE HealthCare launches bkActiv S series – part of the bkPortfolio family of Active Imaging systems.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.